ROBERT I TEPPER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT I TEPPER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT I TEPPER. ROBERT I TEPPER is President, R&D in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and Director in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in Kala Pharmaceuticals, Inc. ($KALA) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in Allena Pharmaceuticals, Inc. ($ALNA) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and Director in Jounce Therapeutics, Inc. ($JNCE) and Director in Neon Therapeutics, Inc. ($NTGN).
Latest Insider Trading Transactions of ROBERT I TEPPER
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALNA, CNST, CTMX, GBT, JNCE, KALA, MLNM, NTGN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2020 | JNCE | Jounce Therapeutic ... | TEPPER ROBERT I | Director | Option Exercise | A | 7.58 | 13,550 | 102,709 | 13,550 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | TEPPER ROBERT I | Director | Option Exercise | D | 4.64 | 18,500 | 85,840 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | TEPPER ROBERT I | Director | Option Exercise | D | 16.00 | 14,000 | 224,000 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | TEPPER ROBERT I | Director | Sell | D | 0.00 | 9,741,636 | 0 | 0 | 9.7 M to 0 (-100.00 %) |
| Jun 27 2019 | NTGN | Neon Therapeutics, ... | TEPPER ROBERT I | Director | Option Exercise | A | 4.64 | 18,500 | 85,840 | 18,500 | |
| Jun 13 2019 | JNCE | Jounce Therapeutic ... | TEPPER ROBERT I | Director | Option Exercise | A | 4.46 | 15,700 | 70,022 | 15,700 | |
| Jun 10 2019 | CNST | CONSTELLATION PHAR ... | TEPPER ROBERT I | Director | Option Exercise | A | 9.12 | 13,171 | 120,120 | 13,171 | |
| Jun 07 2019 | ALNA | Allena Pharmaceuti ... | TEPPER ROBERT I | Director | Option Exercise | A | 5.59 | 14,000 | 78,260 | 14,000 | |
| Aug 24 2018 | CNST | CONSTELLATION PHAR ... | TEPPER ROBERT I | Director | Option Exercise | X | 1.55 | 51,032 | 79,100 | 0 | |
| Aug 24 2018 | CNST | CONSTELLATION PHAR ... | TEPPER ROBERT I | Director | Buy | X | 1.55 | 51,032 | 79,100 | 3,034,083 | 3 M to 3 M (+1.71 %) |
| Jul 24 2018 | CNST | CONSTELLATION PHAR ... | TEPPER ROBERT I | Director | Option Exercise | C | 0.00 | 1,000,000 | 0 | 0 | |
| Jul 24 2018 | CNST | CONSTELLATION PHAR ... | TEPPER ROBERT I | Director | Option Exercise | C | 0.00 | 3,107,930 | 0 | 0 | |
| Jul 24 2018 | CNST | CONSTELLATION PHAR ... | TEPPER ROBERT I | Director | Option Exercise | C | 0.00 | 2,285,640 | 0 | 0 | |
| Jul 24 2018 | CNST | CONSTELLATION PHAR ... | TEPPER ROBERT I | Director | Option Exercise | C | 0.00 | 1,086,411 | 0 | 0 | |
| Jul 24 2018 | CNST | CONSTELLATION PHAR ... | TEPPER ROBERT I | Director | Option Exercise | C | 0.00 | 10,650,000 | 0 | 0 | |
| Jul 24 2018 | CNST | CONSTELLATION PHAR ... | TEPPER ROBERT I | Director | Option Exercise | C | 0.00 | 11,000,000 | 0 | 0 | |
| Jul 24 2018 | CNST | CONSTELLATION PHAR ... | TEPPER ROBERT I | Director | Buy | P | 15.00 | 266,667 | 4,000,005 | 2,983,051 | 2.7 M to 3 M (+9.82 %) |
| Jul 24 2018 | CNST | CONSTELLATION PHAR ... | TEPPER ROBERT I | Director | Buy | C | 0.00 | 2,705,334 | 0 | 2,716,384 | 11.1 K to 2.7 M (+24,482.66 %) |
| Jun 21 2018 | JNCE | Jounce Therapeutic ... | TEPPER ROBERT I | Director | Option Exercise | A | 7.92 | 13,550 | 107,316 | 13,550 | |
| Jun 12 2018 | ALNA | Allena Pharmaceuti ... | TEPPER ROBERT I | Director | Option Exercise | A | 13.52 | 10,182 | 137,661 | 10,182 | |
| Nov 06 2017 | ALNA | Allena Pharmaceuti ... | TEPPER ROBERT I | Director | Option Exercise | C | 0.00 | 4,629,630 | 0 | 0 | |
| Nov 06 2017 | ALNA | Allena Pharmaceuti ... | TEPPER ROBERT I | Director | Option Exercise | C | 0.00 | 6,122,448 | 0 | 0 | |
| Nov 06 2017 | ALNA | Allena Pharmaceuti ... | TEPPER ROBERT I | Director | Buy | P | 14.00 | 215,000 | 3,010,000 | 2,790,964 | 2.6 M to 2.8 M (+8.35 %) |
| Nov 06 2017 | ALNA | Allena Pharmaceuti ... | TEPPER ROBERT I | Director | Buy | C | 0.00 | 2,575,964 | 0 | 2,575,964 | 0 to 2.6 M |
| Oct 04 2017 | CTMX | CytomX Therapeutic ... | TEPPER ROBERT I | 10% Owner | Sell | S | 24.34 | 24,777 | 603,072 | 29,516 | 54.3 K to 29.5 K (-45.64 %) |
| Sep 21 2017 | CTMX | CytomX Therapeutic ... | TEPPER ROBERT I | 10% Owner | Sell | S | 18.00 | 20,000 | 360,000 | 54,293 | 74.3 K to 54.3 K (-26.92 %) |
| Jul 26 2017 | KALA | Kala Pharmaceutica ... | TEPPER ROBERT I | Director | Option Exercise | C | 7.50 | 33,333 | 249,998 | 33,333 | |
| Jul 26 2017 | KALA | Kala Pharmaceutica ... | TEPPER ROBERT I | Director | Option Exercise | C | 0.00 | 173,611 | 0 | 0 | |
| Jul 26 2017 | KALA | Kala Pharmaceutica ... | TEPPER ROBERT I | Director | Option Exercise | C | 0.00 | 2,265,764 | 0 | 0 | |
| Jul 26 2017 | KALA | Kala Pharmaceutica ... | TEPPER ROBERT I | Director | Option Exercise | C | 0.00 | 2,500,000 | 0 | 0 | |
| Jul 26 2017 | KALA | Kala Pharmaceutica ... | TEPPER ROBERT I | Director | Option Exercise | C | 0.00 | 3,677,374 | 0 | 0 | |
| Jul 26 2017 | KALA | Kala Pharmaceutica ... | TEPPER ROBERT I | Director | Buy | C | 0.00 | 1,621,092 | 0 | 1,621,092 | 0 to 1.6 M |
| Jul 21 2017 | KALA | Kala Pharmaceutica ... | TEPPER ROBERT I | Director | Option Exercise | A | 15.00 | 12,960 | 194,400 | 12,960 | |
| Jun 30 2017 | CTMX | CytomX Therapeutic ... | TEPPER ROBERT I | 10% Owner | Sell | S | 16.00 | 15,000 | 240,000 | 44,777 | 59.8 K to 44.8 K (-25.09 %) |
| Apr 10 2017 | GBT | Global Blood Thera ... | TEPPER ROBERT I | 10% Owner | Sell | S | 33.23 | 31,225 | 1,037,576 | 229,773 | 261 K to 229.8 K (-11.96 %) |
| Feb 03 2017 | JNCE | Jounce Therapeutic ... | TEPPER ROBERT I | Director | Option Exercise | C | 0.00 | 11,250,000 | 0 | 0 | |
| Feb 03 2017 | JNCE | Jounce Therapeutic ... | TEPPER ROBERT I | Director | Option Exercise | C | 0.00 | 35,750,000 | 0 | 0 | |
| Feb 03 2017 | JNCE | Jounce Therapeutic ... | TEPPER ROBERT I | Director | Buy | C | 0.00 | 3,048,780 | 0 | 3,048,780 | 0 to 3 M |
| Feb 03 2017 | JNCE | Jounce Therapeutic ... | TEPPER ROBERT I | Director | Buy | C | 0.00 | 9,688,344 | 0 | 10,230,349 | 542 K to 10.2 M (+1,787.50 %) |
| Feb 13 2007 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Sell | S | 11.36 | 22,500 | 255,600 | 105,137 | 127.6 K to 105.1 K (-17.63 %) |
| Nov 20 2006 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Sell | S | 11.49 | 6,761 | 77,684 | 127,375 | 134.1 K to 127.4 K (-5.04 %) |
| Nov 20 2006 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Sell | S | 11.50 | 8,239 | 94,749 | 134,136 | 142.4 K to 134.1 K (-5.79 %) |
| Oct 31 2006 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Sell | S | 11.84 | 1,300 | 15,392 | 142,375 | 143.7 K to 142.4 K (-0.90 %) |
| Oct 31 2006 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Sell | S | 11.85 | 17,000 | 201,450 | 143,675 | 160.7 K to 143.7 K (-10.58 %) |
| Oct 31 2006 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Sell | S | 11.86 | 14,500 | 171,970 | 160,675 | 175.2 K to 160.7 K (-8.28 %) |
| Oct 31 2006 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Sell | S | 11.87 | 10,000 | 118,700 | 175,175 | 185.2 K to 175.2 K (-5.40 %) |
| Oct 31 2006 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Sell | S | 11.88 | 7,500 | 89,100 | 185,175 | 192.7 K to 185.2 K (-3.89 %) |
| Oct 31 2006 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Sell | S | 11.90 | 2,000 | 23,800 | 192,675 | 194.7 K to 192.7 K (-1.03 %) |
| Oct 31 2006 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Sell | S | 11.91 | 7,500 | 89,325 | 194,675 | 202.2 K to 194.7 K (-3.71 %) |
| Oct 31 2006 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Sell | S | 11.92 | 200 | 2,384 | 202,175 | 202.4 K to 202.2 K (-0.10 %) |
| Aug 10 2006 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Sell | S | 9.87 | 1,700 | 16,779 | 200,675 | 202.4 K to 200.7 K (-0.84 %) |
| Aug 01 2006 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Option Exercise | M | 3.94 | 75,000 | 295,313 | 0 | |
| Aug 01 2006 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Buy | M | 3.94 | 75,000 | 295,313 | 202,375 | 127.4 K to 202.4 K (+58.88 %) |
| Mar 08 2006 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Grant | A | 0.00 | 59,000 | 0 | 124,968 | 66 K to 125 K (+89.44 %) |
| Sep 19 2005 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Grant | A | 0.00 | 45,000 | 0 | 65,671 | 20.7 K to 65.7 K (+217.70 %) |
| Mar 07 2005 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Option Exercise | A | 8.41 | 212,500 | 1,787,125 | 212,500 | |
| Sep 02 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Option Exercise | A | 12.09 | 100,625 | 1,216,556 | 100,625 | |
| Sep 02 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Gift | G | 0.00 | 500 | 0 | 17,334 | 17.8 K to 17.3 K (-2.80 %) |
| Apr 15 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Sell | S | 17.55 | 100 | 1,755 | 0 | 100 to 0 (-100.00 %) |
| Apr 15 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Sell | S | 17.56 | 5,316 | 93,349 | 100 | 5.4 K to 100 (-98.15 %) |
| Apr 01 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Option Exercise | M | 4.95 | 9,988 | 49,474 | 12,500 | |
| Apr 01 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Option Exercise | M | 4.72 | 10,012 | 47,245 | 39,108 | |
| Apr 01 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Sell | S | 17.00 | 20,000 | 340,000 | 16,999 | 37 K to 17 K (-54.06 %) |
| Apr 01 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Buy | M | 4.72 | 10,012 | 47,245 | 36,999 | 27 K to 37 K (+37.10 %) |
| Apr 01 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Buy | M | 4.95 | 9,988 | 49,474 | 26,987 | 17 K to 27 K (+58.76 %) |
| Mar 02 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Option Exercise | M | 4.72 | 20,000 | 94,376 | 49,120 | |
| Mar 02 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Sell | S | 17.95 | 20,000 | 359,000 | 16,999 | 37 K to 17 K (-54.06 %) |
| Mar 02 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Buy | M | 4.72 | 20,000 | 94,376 | 36,999 | 17 K to 37 K (+117.65 %) |
| Mar 02 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Option Exercise | M | 4.72 | 20,000 | 94,376 | 49,120 | |
| Mar 02 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Sell | S | 17.95 | 20,000 | 359,000 | 16,999 | 37 K to 17 K (-54.06 %) |
| Mar 02 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Buy | M | 4.72 | 20,000 | 94,376 | 36,999 | 17 K to 37 K (+117.65 %) |
| Feb 27 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Option Exercise | A | 17.77 | 100,625 | 1,788,106 | 100,625 | |
| Feb 27 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Gift | G | 0.00 | 2,000 | 0 | 16,999 | 19 K to 17 K (-10.53 %) |
| Feb 27 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Option Exercise | A | 17.77 | 100,625 | 1,788,106 | 100,625 | |
| Feb 27 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Gift | G | 0.00 | 2,000 | 0 | 16,999 | 19 K to 17 K (-10.53 %) |
| Feb 03 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Option Exercise | M | 4.95 | 20,000 | 99,066 | 22,488 | |
| Feb 03 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Sell | S | 17.65 | 20,000 | 353,000 | 18,999 | 39 K to 19 K (-51.28 %) |
| Feb 03 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Buy | M | 4.95 | 20,000 | 99,066 | 38,999 | 19 K to 39 K (+105.27 %) |
| Feb 03 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Option Exercise | M | 4.95 | 20,000 | 99,066 | 22,488 | |
| Feb 03 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Sell | S | 17.65 | 20,000 | 353,000 | 18,999 | 39 K to 19 K (-51.28 %) |
| Feb 03 2004 | MLNM | MILLENNIUM PHARMAC ... | TEPPER ROBERT I | President, R&D | Buy | M | 4.95 | 20,000 | 99,066 | 38,999 | 19 K to 39 K (+105.27 %) |
Page: 1